These factors include but are not limited to those described under “Risk Factors” in ZoomInfo’s registration statement relating to the offering. ZoomInfo Company / Investor Contact: Jeremiah Sisitsky VP of Investor Relations 617-826-2068 IR@zoominfo.com. The GoHealth IPO reversed lower in its first day of... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! ZoomInfo Investor Contact: Jeremiah Sisitsky VP of Investor Relations 617-826-2068 IR@zoominfo.com. View Procad Technologies (www.procad-tech.com) location in Pennsylvania, United States , revenue, industry and description. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Jeremiah Sisitsky Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. After that, it adopted the name of ZoomInfo, a company founded in 2000. It said the deal was "multiple times oversubscribed," meaning the request for shares was higher than what was made available. This press release contains forward-looking statements. Investors.com will undergo scheduled maintenance tonight from 8:00 PM to 2:00 AM ET and some features may be unavailable. The combined company reported pro-forma revenue of $334.6 million in 2019, with a net loss of $50.9 million. ZoomInfo Technologies. ZoomInfo intends to use the net proceeds from the offering to redeem all outstanding Series A preferred units of ZoomInfo Holdings LLC, its indirect subsidiary following the initial public offering (“ZoomInfo OpCo”), for approximately $274 million, to repay all outstanding $370 million aggregate principal amount of its second lien term loans, to repay $35 million of outstanding borrowings under its first lien revolving credit facility, to purchase outstanding ZoomInfo OpCo equity interests from certain equity holders for approximately $43 million, to pay certain expenses related to this offering, and for general corporate purposes. Company Financials + 14 Analysts. The proposed offering of these securities will be made only by means of a prospectus. Vote every day and help us win! Copies of the registration statement can be accessed through the Securities and Exchange Commission’s website at www.sec.gov. ZoomInfo is a leading go-to-market intelligence platform for sales and marketing teams. Please follow Brian Deagon on Twitter at @IBD_BDeagon for more on tech stocks, analysis and financial markets. Ownership data provided by Refinitiv and Estimates data provided by FactSet. Jeremiah SisitskyVP of Investor Relations Find related and similar companies as … IBD has been nominated for five Benzinga Global Fintech Awards. Forward-looking statements include all statements that are not historical facts. The company says it has 202,000 paying users, serving 15,000 companies, with market intelligence and data analytics on 14 million companies. Copies of the prospectus relating to this offering, when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at (866) 803-9204 or by email at prospectus-eq_fin@jpmchase.com; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014.